HEWA Stock Overview
HealthWarehouse.com, Inc. operates an online and mail order pharmacy.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
HealthWarehouse.com, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.11 |
52 Week High | US$0.23 |
52 Week Low | US$0.10 |
Beta | 0.25 |
1 Month Change | -22.03% |
3 Month Change | -16.65% |
1 Year Change | -33.27% |
3 Year Change | -49.38% |
5 Year Change | -71.03% |
Change since IPO | -97.10% |
Recent News & Updates
Recent updates
Shareholder Returns
HEWA | US Consumer Retailing | US Market | |
---|---|---|---|
7D | -16.0% | 0.8% | 2.1% |
1Y | -33.3% | 23.8% | 30.4% |
Return vs Industry: HEWA underperformed the US Consumer Retailing industry which returned 23.8% over the past year.
Return vs Market: HEWA underperformed the US Market which returned 30.4% over the past year.
Price Volatility
HEWA volatility | |
---|---|
HEWA Average Weekly Movement | n/a |
Consumer Retailing Industry Average Movement | 4.6% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.7% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: HEWA's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine HEWA's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Joseph Peters | https://www.healthwarehouse.com |
HealthWarehouse.com, Inc. operates an online and mail order pharmacy. The company markets a range of generic, brand name, and pet prescription medicines, as well as over-the-counter (OTC) medications and products. It sells its products in 50 states and the District of Columbia in the United States to focus on the out-of-pocket prescription drug market.
HealthWarehouse.com, Inc. Fundamentals Summary
HEWA fundamental statistics | |
---|---|
Market cap | US$6.04m |
Earnings (TTM) | -US$1.69m |
Revenue (TTM) | US$20.32m |
0.3x
P/S Ratio-3.6x
P/E RatioIs HEWA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HEWA income statement (TTM) | |
---|---|
Revenue | US$20.32m |
Cost of Revenue | US$8.06m |
Gross Profit | US$12.26m |
Other Expenses | US$13.94m |
Earnings | -US$1.69m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.031 |
Gross Margin | 60.33% |
Net Profit Margin | -8.29% |
Debt/Equity Ratio | 0.0% |
How did HEWA perform over the long term?
See historical performance and comparison